Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
104.60
-1.10 (-1.04%)
At close: Dec 5, 2025, 4:00 PM EST
105.34
+0.74 (0.71%)
After-hours: Dec 5, 2025, 6:15 PM EST
Rhythm Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6,981 | 3,440 | 2,717 | 1,641 | 502 | 1,314 | |
| Market Cap Growth | 89.40% | 26.64% | 65.56% | 227.08% | -61.83% | 30.31% | |
| Enterprise Value | 6,678 | 3,397 | 2,419 | 1,295 | 176 | 1,116 | |
| Last Close Price | 104.60 | 55.98 | 45.97 | 29.12 | 9.98 | 29.73 | |
| PS Ratio | 38.20 | 26.44 | 35.09 | 69.42 | 159.06 | - | |
| PB Ratio | 46.87 | 20.91 | 16.00 | 6.21 | 1.77 | 7.89 | |
| P/TBV Ratio | 48.72 | 221.17 | 16.69 | 6.40 | 1.80 | 7.89 | |
| EV/Sales Ratio | 38.30 | 26.10 | 31.24 | 54.79 | 55.81 | - | |
| Debt / Equity Ratio | 0.38 | 0.69 | 0.63 | 0.29 | 0.01 | 0.02 | |
| Asset Turnover | 0.40 | 0.36 | 0.22 | 0.07 | 0.01 | - | |
| Inventory Turnover | 1.03 | 0.98 | 1.61 | 1.41 | - | - | |
| Quick Ratio | 4.31 | 2.94 | 5.27 | 8.53 | 6.81 | 9.60 | |
| Current Ratio | 4.75 | 3.24 | 5.58 | 8.90 | 7.10 | 10.10 | |
| Return on Equity (ROE) | -85.79% | -155.91% | -85.10% | -66.05% | -30.89% | -59.88% | |
| Return on Assets (ROA) | -26.74% | -45.77% | -32.22% | -31.45% | -41.15% | -34.45% | |
| Return on Capital (ROIC) | -34.49% | -59.75% | -37.22% | -35.62% | -46.59% | -37.59% | |
| Return on Capital Employed (ROCE) | -46.30% | -95.90% | -66.40% | -52.30% | -59.40% | -80.80% | |
| Earnings Yield | -2.83% | -7.58% | -6.80% | -11.04% | -13.88% | -10.20% | |
| FCF Yield | -1.56% | -3.31% | -5.01% | -10.59% | -29.19% | -9.30% | |
| Buyback Yield / Dilution | -5.39% | -5.76% | -10.65% | -5.08% | -12.40% | -21.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.